The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
Editor's Choice

Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023

AUG 22, 2023
New study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population
Pharma & Human Health

New study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population

AUG 22, 2023
Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial
Clinical & Manufacturing

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial

AUG 18, 2023
A fungus gets comfortable: Aspergillus fumigatus adapts to life in humans and shapes their lung microbiome
Infectious Disease & AMR

A fungus gets comfortable: Aspergillus fumigatus adapts to life in humans and shapes their lung microbiome

AUG 17, 2023
Multiple sclerosis: fateful immune cell activation in gut made visible
Gut-Brain Axis

Multiple sclerosis: fateful immune cell activation in gut made visible

AUG 15, 2023
Engineered probiotic developed to treat multiple sclerosis
Biotics and Supplements

Engineered probiotic developed to treat multiple sclerosis

AUG 14, 2023
Bactolife Raises EUR 30 million in Series A Financing
Finance

Bactolife Raises EUR 30 million in Series A Financing

AUG 8, 2023
Treating bladder infections with viruses
Infectious Disease & AMR

Treating bladder infections with viruses

JUL 25, 2023
Distinguishing Strains in Microbiome Samples: Considerations and Challenges
Editor's Choice

Distinguishing Strains in Microbiome Samples: Considerations and Challenges

JUL 19, 2023
Ensuring standardised data collection for microbiome research, a sit down with DNA Genotek’s Heloise Breton and Austin Udocor
Pharma & Human Health

Ensuring standardised data collection for microbiome research, a sit down with DNA Genotek’s Heloise Breton and Austin Udocor

JUL 12, 2023
Dutch government reserves €200 million for Holomicrobiome Institute
Finance

Dutch government reserves €200 million for Holomicrobiome Institute

JUL 5, 2023